{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_references_@count in root_references_@count (approximate match)
Status:
Investigational
Source:
INN:lusacomfar alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:demupitamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03472027: Phase 1 Interventional Completed Melanoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:gresonitamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:peresolimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:anetumab corixetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:vurolenatide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:bovhyaluronidase azoximer [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02565758: Phase 1 Interventional Completed Advanced Solid Tumors
(2015)
Source URL:
Class:
PROTEIN
